Bioprinting Toward Organ Fabrication: Challenges and Future Trends

IEEE Transactions on Biomedical Engineering (Impact Factor: 2.23). 01/2013; DOI: 10.1109/TBME.2013.2243912
Source: PubMed

ABSTRACT Tissue engineering has been a promising field of research, offering hope for bridging the gap between organ shortage and transplantation needs. However, building three-dimensional (3D) vascularized organs remains the main technological barrier to be overcome. Organ printing, which is defined as computer-aided additive biofabrication of 3D cellular tissue constructs, has shed light on advancing this field into a new era. Organ printing takes advantage of rapid prototyping (RP) technology to print cells, biomaterials, and cell-laden biomaterials individually or in tandem, layer by layer, directly creating 3D tissue-like structures. Here, we overview RP-based bioprinting approaches and discuss the current challenges and trends towards fabricating living organs for transplant in the near future.

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Due to their low self-repair ability, cartilage defects that result from joint injury, aging, or osteoarthritis, are the most often irreversible and are a major cause of joint pain and chronic disability. So, in recent years, researchers and surgeons have been working hard to elaborate cartilage repair interventions for patients who suffer from cartilage damage. However, current methods do not perfectly restore hyaline cartilage and may lead to the apparition of fibro-or hypertrophic cartilage. In the next years, the development of new strategies using adult stem cells, in scaffolds, with supplementation of culture medium and/or culture in low oxygen tension should improve the quality of neoformed cartilage. Through these solutions, some of the latest technologies start to bring very promising results in repairing cartilage from traumatic injury or chondropathies. This review discusses the current knowledge about the use of adult stem cells in the context of cartilage tissue engineering and presents clinical trials in progress, as well as in the future, especially in the field of bioprinting stem cells.
    Stem cell International 01/2015; · 2.81 Impact Factor
  • 09/2014; 2(3):231-238. DOI:10.1007/s40436-014-0081-2
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The scarcity of organs for transplant has led to large waiting lists of very sick patients. In drug development, the time required for human trials greatly increases the time to market. Drug companies are searching for alternative environments where the in-vivo conditions can be closely replicated. Both these problems could be addressed by manufacturing artificial human tissue. Recently, researchers in tissue engineering have developed tissue generation methods based on 3-D printing to fabricate artificial human tissue. Broadly, these methods could be classified as laser-assisted and laser free. The former have very fine spatial resolutions (10s of $\mu$m) but suffer from slow speed ( $< 10^2$ drops per second). The later have lower spatial resolutions (100s of $\mu$ m) but are very fast (up to $5\times 10^3$ drops per second). In this paper we review state-of-the-art methods in each of these classes and provide a comparison based on reported resolution, printing speed, cell density and cell viability.


Available from
Aug 22, 2014
Available from